UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 380

Sortiert nach

14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans

The European respiratory journal, 2011-01, Vol.37 (1), p.119-128

2011

Volltextzugriff (PDF)

Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity

American journal of physiology. Heart and circulatory physiology, 2010-09, Vol.299 (3), p.H925-H931

2010

Volltextzugriff (PDF)

Sympathetic overactivity due to sleep fragmentation is associated with elevated diurnal systolic blood pressure in healthy elderly subjects: the PROOF-SYNAPSE study

European heart journal, 2013-07, Vol.34 (28), p.2122-2131

2013

Volltextzugriff (PDF)

Self-reported sleepiness and not the apnoea hypopnoea index is the best predictor of sleepiness-related accidents in obstructive sleep apnoea

Scientific reports, 2020-10, Vol.10 (1), p.16267-16267, Article 16267

2020

Volltextzugriff (PDF)

Fixed-pressure CPAP versus auto-adjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomised clinical trial

Thorax, 2016-08, Vol.71 (8), p.726-733

2016

Volltextzugriff (PDF)

The multifaceted aspects of sleep and sleep-wake disorders following stroke

Revue neurologique, 2023-10, Vol.179 (7), p.782-792

2023

Volltextzugriff (PDF)

Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives

The European respiratory journal, 2008-10, Vol.32 (4), p.1082-1095

2008

Volltextzugriff (PDF)

Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure

Respiratory medicine, 2016-03, Vol.112, p.119-125

2016

Volltextzugriff (PDF)

Obstructive sleep apnoea syndrome in patients living with diabetes: Which patients should be screened?

Diabetes & metabolism, 2019-04, Vol.45 (2), p.91-101

2019

Volltextzugriff (PDF)

Sleep apnoea syndrome in 2011: current concepts and future directions

European respiratory review, 2011-09, Vol.20 (121), p.134-146

2011

Volltextzugriff (PDF)

The Upper Airway Resistance Syndrome

Respiration, 2012-01, Vol.83 (6), p.559-566

2012

Volltextzugriff (PDF)

[OP.8B.02] ARTERIAL STIFFNESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME: AN INDIVIDUAL META-ANALYSIS OF CONTRIBUTING FACTORS

Journal of hypertension, 2016-09, Vol.34 Suppl 2 - ESH 2016 Abstract Book (Supplement 2), p.e100-e100

2016

Volltextzugriff (PDF)

A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep, and blood pressure

Journal of applied physiology (1985), 2009-07, Vol.107 (1), p.17-24

2009

Volltextzugriff (PDF)

Insomnia symptoms combined with nocturnal hypoxia associate with cardiovascular comorbidity in the European sleep apnea cohort (ESADA)

Sleep & breathing, 2019-09, Vol.23 (3), p.805-814

2019

Volltextzugriff (PDF)

Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome

The European respiratory journal, 2008-05, Vol.31 (5), p.1046-1053

2008

Volltextzugriff (PDF)

Telemonitoring in continuous positive airway pressure-treated patients with obstructive sleep apnoea syndrome: An algorithm proposal

Revue des maladies respiratoires, 2020-09, Vol.37 (7), p.550

2020

Volltextzugriff (PDF)

8C.08: CONTINUOUS POSITIVE AIRWAY PRESSURE IS EFFICIENT TO DECREASE BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION. RESULTS FROM THE RHOOSAS STUDY

Journal of hypertension, 2015-06, Vol.33 Suppl 1 - ESH 2015 Abstract Book (Supplement 1), p.e112-e112

2015

Volltextzugriff (PDF)

Respective effects of OSA treatment and angiotensin receptor blocker on aldosterone in hypertensive OSA patients: A randomized cross-over controlled trial

International journal of cardiology, 2014-12, Vol.177 (2), p.629-631

2014

Volltextzugriff (PDF)

Cardiovascular morbidity associated with obstructive sleep apnea syndrome

Revue des maladies respiratoires, 2014-04, Vol.31 (4), p.375

2014

Volltextzugriff (PDF)

Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?

The European respiratory journal, 2008-07, Vol.32 (1), p.113-120

2008

Volltextzugriff (PDF)

The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome

Respiratory physiology & neurobiology, 2012-03, Vol.180 (2), p.298-304

2012

Volltextzugriff (PDF)

Reprint of : Management of obstructive sleep apnea syndrome in people living with diabetes: context, screening, indications and treatment modalities: context, screening, indications and treatment modalities: a French position statement

Revue des maladies respiratoires, 2018-12, Vol.35 (10), p.1067-1089

2018

Volltextzugriff (PDF)

1291 IN SLEEP APNEA SYNDROME, NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH THE SEVERITY OF INTERMITTENT HYPOXIA AND MORE SEVERE ENDOTHELIAL DYSFUNCTION

Journal of hepatology, 2012-04, Vol.56, p.S509-S510

2012

Volltextzugriff (PDF)

L’IGF-1 : un marqueur du risque cardiovasculaire chez les patients ayant un syndrome d’apnée obstructif du sommeil (SAOS)

Annales d'endocrinologie, 2016-09, Vol.77 (4), p.255-255

2016

Volltextzugriff (PDF)

1 – 25 von 380

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(291)
Mit Volltextzugriff
(265)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(92)
Humans
(89)
Male
(53)
Respiratory System
(52)
Female
(48)
Biological And Medical Sciences
(34)
Adult
(33)
Life Sciences
(31)
Medical Sciences
(29)
Middle Aged
(29)
Sleep Apnea
(25)
Physics
(24)
Aged
(19)
Cardiac & Cardiovascular Systems
(19)
Cardiovascular System & Cardiology
(19)
Polysomnography
(19)
Continuous Positive Airway Pressure
(18)
Nuclear Experiment
(15)
Risk Factors
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans

Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity

Sympathetic overactivity due to sleep fragmentation is associated with elevated diurnal systolic blood pressure in healthy elderly subjects: the PROOF-SYNAPSE study

Self-reported sleepiness and not the apnoea hypopnoea index is the best predictor of sleepiness-related accidents in obstructive sleep apnoea

Fixed-pressure CPAP versus auto-adjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomised clinical trial

Clusters of sleep apnoea phenotypes: A large pan‐European study from the European Sleep Apnoea Database (ESADA)

The multifaceted aspects of sleep and sleep-wake disorders following stroke

Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives

Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure

Obstructive sleep apnoea syndrome in patients living with diabetes: Which patients should be screened?

Sleep apnoea syndrome in 2011: current concepts and future directions

The Upper Airway Resistance Syndrome

[OP.8B.02] ARTERIAL STIFFNESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME: AN INDIVIDUAL META-ANALYSIS OF CONTRIBUTING FACTORS

A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep, and blood pressure

Insomnia symptoms combined with nocturnal hypoxia associate with cardiovascular comorbidity in the European sleep apnea cohort (ESADA)

Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome

Telemonitoring in continuous positive airway pressure-treated patients with obstructive sleep apnoea syndrome: An algorithm proposal

8C.08: CONTINUOUS POSITIVE AIRWAY PRESSURE IS EFFICIENT TO DECREASE BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION. RESULTS FROM THE RHOOSAS STUDY

Respective effects of OSA treatment and angiotensin receptor blocker on aldosterone in hypertensive OSA patients: A randomized cross-over controlled trial

Cardiovascular morbidity associated with obstructive sleep apnea syndrome

Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?

The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome

Reprint of : Management of obstructive sleep apnea syndrome in people living with diabetes: context, screening, indications and treatment modalities: context, screening, indications and treatment modalities: a French position statement

1291 IN SLEEP APNEA SYNDROME, NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH THE SEVERITY OF INTERMITTENT HYPOXIA AND MORE SEVERE ENDOTHELIAL DYSFUNCTION

L’IGF-1 : un marqueur du risque cardiovasculaire chez les patients ayant un syndrome d’apnée obstructif du sommeil (SAOS)

Suchergebnisse filtern